showed paraparesis, whereas none of the 10 mice inoculated with ATL cells subcutaneously (S.C.) showed paraparesis. In the I.M. group, PCR detected HTLV-1-specific genes in the thoracic and lumbar vertebrae; however, in the S.C. group, the vertebrae were negative for HTLV-1 genes. Histological analysis revealed a particularly high incidence of tumors, characterized by accumulation of the injected cells, in the thoracic vertebrae of mice in the I.M. group. Tumor cell infiltration was relatively high in the bone marrow. Spinal cord compression caused by invasion of the tumor mass outside the pia mater was observed in the thoracic vertebrae of the spinal cord. In conclusion, we have reported a mouse model of tumor growth with paraparesis that may be used to assess novel therapeutic agents for ATL with CNS involvement.
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| ME THODS
NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) female mice, 4 weeks of age, were obtained from Charles River Japan (Tokyo, Japan). The mice were housed in autoclaved polycarbonate cages with paper chip bedding (Japan SLC, Inc., Hamamatsu, Japan) covered with filter caps (CLEA Japan, Inc. Tokyo, Japan), placed in isolation cabinets (BBH Unit, Seobit Inc., Tokyo, Japan), and fed a sterile irradiated diet (CLEA Japan) with free access to acidified autoclaved water. The animal room was maintained under barrier-sustained conditions and controlled temperature (23 ± 2°C) and lighting (12-hour light/dark cycle).
After 1 week of preliminary care, the mice were used for experiments.
This study was carried out in strict accordance with the Guidelines inoculation, the injection needle was inserted almost parallel to the body axis. For I.M. inoculation, the injection needle was inserted at an angle of 45° to the body axis. Animals were euthanized by isoflurane inhalation by 4 weeks after inoculation. The mice were autopsied and their organs collected for histopathological studies.
| RE SULTS
Of the 10 mice inoculated with S1T cells I.M. at 5 weeks of age, 8 (80%)
showed spastic paraparesis, whereas none of the 10 mice inoculated with S1T cells S.C. showed spastic paraparesis ( Figure 1B , Video S1).
The body weight of mice in the I.M. group decreased 2 weeks after inoculation, whereas that of mice in the S.C. group increased continuously during the observation period ( Figure 1C 
| D ISCUSS I ON
Currently, the method used to generate a mouse model of ATL involves S.C. inoculation of ATL cells into the postauricular region of immunodeficient mice. 6 This model is useful for determining therapeutic strategies for ATL. 9 However, it is difficult to establish an animal model of ATL with CNS involvement. Here, we showed the feasibility of generating a mouse model of ATL with CNS involvement by injecting cells I.M.
I.M. administration is a common parenteral route used in large animals
and humans but is often avoided in smaller species because of their reduced muscle masses. 10 In conclusion, here we report a mouse model of tumor growth with paraparesis that may be used to assess novel therapeutic agents for the treatment of ATL with CNS involvement.
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